Clinical Evidence

Peptides with completed or active human clinical trials. These compounds have the strongest evidence base, with data from controlled studies in human subjects.

Looking for preclinical and animal study data? View all research

94 trialsPhase 4

Anastrozole

Anastrozole

Anastrozole is a third-generation non-steroidal aromatase inhibitor FDA-approved for breast cancer treatment. In the hormonal health community it is w...

Well-evidencedLearn more
83 trialsPhase 4

Glucagon

Glucagon

Glucagon is a 29-amino-acid peptide hormone produced by alpha cells of the pancreatic islets of Langerhans that acts as the primary counter-regulatory...

EstablishedLearn more
49 trialsPhase 4

Somatostatin

Somatostatin-14

Somatostatin is a 14-amino-acid cyclic peptide hormone produced throughout the body — in the hypothalamus pancreas gastrointestinal tract and immune c...

EstablishedLearn more
11 trialsPhase 2

Oxytocin Nasal

Oxytocin Intranasal Formulation

Intranasal oxytocin is a specific formulation of the neuropeptide oxytocin that delivers the compound directly to the brain via nasal administration p...

EstablishedLearn more
19 trialsPhase 4

Pyroglutamate

Pyroglutamic Acid (5-Oxoproline)

Pyroglutamate (pyroglutamic acid) is a cyclic amino acid formed from glutamine or glutamic acid that occurs naturally in many proteins and has cogniti...

EstablishedLearn more
22 trialsPhase 3

Thyroid Releasing Hormone

Thyrotropin-Releasing Hormone (TRH)

Thyrotropin-Releasing Hormone (TRH) is a tripeptide (pyroglutamyl-histidyl-proline amide) produced by the hypothalamus that stimulates the pituitary t...

EstablishedLearn more
4 trialsPhase 2

NSI-189

NSI-189 Phosphate

NSI-189 is a synthetic aminopyridine-benzylpiperazine compound originally developed by Neuralstem Inc that has demonstrated neurogenic properties in t...

EmergingLearn more